Kolexia
Gambart Marion Pédiatrie
Gambart Marion
Pédiatrie
Hôpital Paule de Viguier
Toulouse, France
82 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Neuroblastome Ostéosarcome Récidive tumorale locale Tumeurs osseuses Tumeurs du cerveau Tumeurs sous-tentorielles Leucémie-lymphome lymphoblastique à précurseurs B et T Leucémies Tumeurs de la thyroïde

Collaborateurs

Voir plus
Thebaud Estelle
Thebaud Estelle
Hôpital Hôtel-Dieu Nantes, Nantes, France
Valteau-Couanet Dominique
Valteau-Couanet Dominique
Gustave-Roussy, Villejuif, France
Schleiermacher Gudrun
Schleiermacher Gudrun
Clcc Institut Curie, Paris, France
Thomassin-Defachelles Anne-Sophie
Thomassin-Defachelles Anne-Sophie
Centre Oscar-Lambret, Lille, France

Industries

Voir plus
B3TSI
12 collaboration(s)
Dernière en 2023
Eusa Pharma
1 collaboration(s)
Dernière en 2022
Chugai
1 collaboration(s)
Dernière en 2022
Bayer
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Discordances iconographiques entre TEP-TDM au 68GA-DOTATOC et scintigraphie à la 123I-mIBG chez une enfant avec neuroblastome réfractaire
10e Journées Francophones de Médecine nucléaire - Biarritz   01 mars 2024
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
European journal of cancer (Oxford, England : 1990)   15 février 2024
NEUROBLU 02: A Phase I Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
Essai Clinique (Advanced Accelerator Applications)   13 février 2024
MICCHADO: Molecular and Immunological Characterisation of High Risk CHildhood Cancer At DiagnOsis, Treatment and Follow-up - Biological Evaluation in Children, Adolescents and Young Adults -
Essai Clinique (Institut Curie)   02 février 2024
E7080-G000-231: An Open-Label, Multicenter Phase 2 Basket Study to Evaluate the Antitumor Activity and Safety of Lenvatinib in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Malignancies
Essai Clinique (Merck & Co.)   08 janvier 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   08 janvier 2024
The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   23 décembre 2023
A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma: A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination With Ifosfamide and Etoposide Versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults With Relapsed or Refractory Osteosarcoma (OLIE)
Essai Clinique (Eisai)   10 octobre 2023
Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer.
Cancer chemotherapy and pharmacology   03 octobre 2023
A Prospective Study of Arterial Spin Labelling in Paediatric Posterior Fossa Tumour Survivors: A Correlation with Neurocognitive Impairment.
Clinical oncology (Royal College of Radiologists (Great Britain))   29 septembre 2023